# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate...
In a recent report, Pablo Zuanic, senior analyst at Zuanic & Associates, analyzes the debt maturities of over 20 multi-stat...
Glass House Brands Inc. (OTCQX: GLASF) (OTC: GHBWF) is about to report financial results for the second quarter ended June 30, ...
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following Preside...
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has completed the previously announced acquisition of a 6,500-square-foot, purp...